Related references
Note: Only part of the references are listed.p53-dependent anticancer effects of leptomycin B on lung adenocarcinoma
Changxia Shao et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Adjuvant Therapy in Non-Small Cell Lung Cancer: Future Treatment Prospects and Paradigms
David P. Carbone et al.
CLINICAL LUNG CANCER (2011)
A gel-based proteomic analysis of the effects of green tea polyphenols on ovariectomized rats
Changxia Shao et al.
NUTRITION (2011)
Survival by histologic subtype in stage IV nonsmall cell lung cancer based on data from the Surveillance, Epidemiology and End Results Program
Karynsa Cetin et al.
Clinical Epidemiology (2011)
Nucleocytoplasmic Shuttling of p62/SQSTM1 and Its Role in Recruitment of Nuclear Polyubiquitinated Proteins to Promyelocytic Leukemia Bodies
Serhiy Pankiv et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Targeted therapies for non-small cell lung cancer
Wolfram C. M. Dempke et al.
LUNG CANCER (2010)
Pain in patients with lung cancer: Pathophysiology and treatment
Sebastiano Mercadante et al.
LUNG CANCER (2010)
4-(Methylnitro-Samino)-1-(3-Pyridyl)-1-Butanone Induces CRM1-Dependent P53 Nuclear Accumulation in Human Bronchial Epithelial Cells
Lixia Chen et al.
TOXICOLOGICAL SCIENCES (2010)
Doxorubicin-induced mitochondrial dysfunction is secondary to nuclear p53 activation in H9c2 cardiomyoblasts
Vilma A. Sardao et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Identification of Nuclear Export Inhibitors with Potent Anticancer Activity In vivo
Sarah C. Mutka et al.
CANCER RESEARCH (2009)
Cancer Treatments: Can We Find Treasures at the Bottom of the Sea?
Mariano Provencio et al.
CLINICAL LUNG CANCER (2009)
The Karyopherin proteins, Crm1 and Karyopherin β1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation
Pauline J. Van der Watt et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
A dual role of p53 in the control of autophagy
Ezgi Tasdemir et al.
AUTOPHAGY (2008)
Involvement of aldolase A in X-ray resistance of human HeLa and UV-1 cells
Jun Lu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Characterization of a stem cell population in lung cancer A549 cells
Ji-Min Sung et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer
Aurelia Noske et al.
CANCER (2008)
CRM1-Mediated Nuclear Export of Proteins and Drug Resistance in Cancer
Joel G. Turner et al.
CURRENT MEDICINAL CHEMISTRY (2008)
RNA aptamer-targeted inhibition of NF-kappa B suppresses non-small cell lung cancer resistance to doxorubicin
Jing Mi et al.
MOLECULAR THERAPY (2008)
Systematic review of multidisciplinary teams in the management of lung cancer
M. Coory et al.
LUNG CANCER (2008)
Improved cytotoxicity of doxorubicin by enhancing its nuclear delivery mediated via nanosized micelles
Jian You et al.
NANOTECHNOLOGY (2008)
Inhibition of Thr-55 phosphorylation restores p53 nuclear localization and sensitizes cancer cells to DNA damage
Xin Cai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Down-regulation of survivin by ultraviolet C radiation is dependent on p53 and results in G2-M arrest in A549 cells
Masato Ikeda et al.
CANCER LETTERS (2007)
Adriamycin-induced myocardial toxicity: New solutions for an old problem?
Delia Outomuro et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
Nuclear export is essential for the tumor-promoting activity of survivin
Shirley K. Knauer et al.
FASEB JOURNAL (2007)
Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1α gene
Xianrang Song et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Doxorubicin-DNA adducts induce a non-topoisomerase II-mediated form of cell death
Lonnie P. Swift et al.
CANCER RESEARCH (2006)
MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy
K Kojima et al.
BLOOD (2005)
Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication
W Wang et al.
NATURE CELL BIOLOGY (2005)
Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms -: Intermediacy of H2O2- and p53-dependent pathways
SW Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
p21/CDKN1A mediates negative regulation of transcription by p53
K Löhr et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Leptomycin B stabilizes and activates p53 in primary prostatic epithelial cells and induces apoptosis in the LNCaP cell line
PS Lecane et al.
PROSTATE (2003)
Sequential activation and inactivation of G2 checkpoints for selective killing of p53-deficient cells by microtubule-active drugs
MV Blagosklonny
ONCOGENE (2002)
Structure and functional properties of the ubiquitin binding protein p62
T Geetha et al.
FEBS LETTERS (2002)
Doxorubicin-induced apoptosis and chemosensitivity in hepatoma cell lines
TKW Lee et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2002)
Cell cycle checkpoint signaling through the ATM and ATR kinases
RT Abraham
GENES & DEVELOPMENT (2001)
A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation
YP Zhang et al.
SCIENCE (2001)
Increase in wild-type p53 stability and transactivational activity by the chemopreventive agent apigenin in keratinocytes
M McVean et al.
CARCINOGENESIS (2000)